[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) 

# Risk: __Variation in protection against re-infections__ (PBN__Risk_1914)

## Property: has_RiskName

Uncertainty in the efficacy of protection against re-infections in symptomatic and asymptomatic individuals.

## Property: has_RiskISO_Impact

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Property: has_RiskISO_Purpose

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_3.md)

## Property: has_RiskOwner

* [healthcare providers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_121.md)
* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)

## Property: has_RiskTechnology

* [research and data analysis technologies](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1312.md)

## Property: has_RiskSubject

* [re-infected individuals](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_1296.md)
* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)

## Property: has_RiskMitigation

* [Evaluate the difference in efficacy between symptomatic and asymptomatic individuals.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2516.md)

## Property: has_RiskDescription

Potential difference in protection against re-infections based on symptomatic status in initial infection.

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskType

* [medical](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_15.md)

## Property: has_RiskGBN

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Property: has_RiskSource

* [pilz_contributions_2022](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_245.md)

